Literature DB >> 19192038

The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study.

A Marengoni1, E von Strauss, D Rizzuto, B Winblad, L Fratiglioni.   

Abstract

OBJECTIVE: We aimed to disentangle the effect of chronic multimorbidity and disability on 3-year functional decline and survival in the elderly.
DESIGN: Prospective cohort study with a mean of follow-up of 2.8 years.
SETTING: Swedish elderly persons from the Kungsholmen Project (1987-2000).
SUBJECTS: A total of 1099 subjects, 77-100 years old, living in the community and institutions. MAIN OUTCOME MEASUREMENTS: Medical diagnoses (based on clinical examination, drug use, medical records and blood tests), and functional assessment (according to Katz Index) at baseline were investigated in relation to functional decline and death occurring during follow-up.
RESULTS: At baseline, 12.1% of participants had disability, and 52.3% were affected by multimorbidity. During follow-up, 363 persons died and 85 worsened in functioning. The number of chronic conditions incrementally increased the risk of functional decline [hazard ratio (HR) increased from 1.5 in subjects with one disease to 6.2 in persons with 4+ diseases]. However, this was not the case for mortality, as the HR of death was the same for people with one disease as well as 4+ diseases (HR=2.3). Baseline disability had the highest impact on survival, independently of number of diseases [HR=8.1; 95% confidence interval (CI)=4.8-13.7 in subjects with one disease and HR=7.7; 95% CI=4.7-12.6 in those with 2+ diseases].
CONCLUSIONS: In the elderly subjects, chronic disability rather than multimorbidity emerged as the strongest negative prognostic factor for functionality and survival.

Entities:  

Mesh:

Year:  2009        PMID: 19192038     DOI: 10.1111/j.1365-2796.2008.02017.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  112 in total

1.  Association of handgrip strength with chronic diseases and multimorbidity: a cross-sectional study.

Authors:  Ching-Lung Cheung; Uyen-Sa D T Nguyen; Eleanor Au; Kathryn C B Tan; Annie W C Kung
Journal:  Age (Dordr)       Date:  2012-02-08

2.  The Impact of Multimorbidity on Resting Metabolic Rate in Community-Dwelling Women over a Ten-Year Period: A Cross-Sectional and Longitudinal Study.

Authors:  A Nagel; A Jungert; A Spinneker; M Neuhäuser-Berthold
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Research priorities in geriatric palliative care: multimorbidity.

Authors:  Christine S Ritchie; Donna M Zulman
Journal:  J Palliat Med       Date:  2013-06-18       Impact factor: 2.947

4.  Inflammation Partially Mediates the Association of Multimorbidity and Functional Limitations in a National Sample of Middle-Aged and Older Adults: The MIDUS Study.

Authors:  Elliot M Friedman; Sharon L Christ; Daniel K Mroczek
Journal:  J Aging Health       Date:  2015-02-02

5.  Age, frailty, disability, institutionalization, multimorbidity or comorbidity. Which are the main targets in older adults?

Authors:  P Abizanda; L Romero; P M Sánchez-Jurado; M Martínez-Reig; S A Alfonso-Silguero; L Rodríguez-Mañas
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

6.  The Association Between Polypharmacy and Physical Function in Older Adults: a Systematic Review.

Authors:  Andreas Katsimpris; Jacob Linseisen; Christa Meisinger; Konstantinos Volaklis
Journal:  J Gen Intern Med       Date:  2019-06-25       Impact factor: 5.128

7.  Tracking Multimorbidity Changes in Diverse Racial/Ethnic Populations Over Time: Issues and Considerations.

Authors:  Ana R Quiñones; Heather G Allore; Anda Botoseneanu; Jason T Newsom; Corey L Nagel; David A Dorr
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-20       Impact factor: 6.053

8.  Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis.

Authors:  C Custodero; R T Mankowski; S A Lee; Z Chen; S Wu; T M Manini; J Hincapie Echeverri; C Sabbà; D P Beavers; J A Cauley; M A Espeland; R A Fielding; S B Kritchevsky; C K Liu; M M McDermott; M E Miller; R P Tracy; A B Newman; W T Ambrosius; M Pahor; S D Anton
Journal:  Ageing Res Rev       Date:  2018-05-25       Impact factor: 10.895

9.  Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults.

Authors:  Sandy S Chang; Shu Chen; Gail J McAvay; Mary E Tinetti
Journal:  J Am Geriatr Soc       Date:  2012-10-04       Impact factor: 5.562

Review 10.  Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways.

Authors:  A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni
Journal:  J Intern Med       Date:  2018-11-22       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.